MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition
MSD has announced the successful completion of its acquisition of Terns Pharmaceuticals, Inc., marking a…
Trending
- MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition
- Madrigal Licenses Gene Therapy Candidate for MASH Treatment
- Citius Oncology Secures $36.5M to Boost LYMPHIR Launch
- Latus Bio Raises $97 Million to Advance Gene Therapies
- FDA Approves LANGLARA Biosimilar Insulin for Diabetes Treatment
- UCB to Acquire Candid Therapeutics in $2.2 Billion Deal
- FDA Expands Auvelity Use for Alzheimer’s Agitation Treatment
- Novo Nordisk Launches Oral Ozempic for Type 2 Diabetes
- Australia Approves First FCS Treatment REDEMPLO by Arrowhead
- Gilead Completes $7.8 Billion Arcellx Acquisition Deal
Top Headlines
Madrigal Licenses Gene Therapy Candidate for MASH Treatment
Madrigal Pharmaceuticals, Inc. has entered into an exclusive global licensing agreement with Arrowhead…
Citius Oncology Secures $36.5M to Boost LYMPHIR Launch
Citius Oncology, Inc. has announced a combined financing package of up to $36.5 million aimed at accelerating the…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
FDA Approves LANGLARA Biosimilar Insulin for Diabetes Treatment
The U.S. Food and Drug Administration has approved LANGLARA™ (insulin glargine-aldy), a biosimilar to Lantus®…
UCB to Acquire Candid Therapeutics in $2.2 Billion Deal
UCB has announced a definitive agreement to acquire Candid Therapeutics in a deal valued at up to $2.2 billion,…
Featured Event
Clinical Trials
Madrigal Licenses Gene Therapy Candidate for MASH Treatment
Madrigal Pharmaceuticals, Inc. has entered into an exclusive global licensing agreement with Arrowhead Pharmaceuticals to develop and commercialize…
Akeso Advances First Trispecific Antibody Into Clinical Trials
Akeso, Inc. has announced that its novel trispecific antibody candidate, AK150, has received Investigational New Drug (IND) clearance from the…
Vima Therapeutics Advances Dystonia Drug Into Phase 2 Trials
Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first…
Akeso and INOVIO Partner on Novel Glioblastoma Combination Trial
Biotechnology companies Akeso, Inc. and INOVIO have announced a clinical trial collaboration and supply agreement to evaluate a new combination…
Novartis Remibrutinib Shows Phase III Success in CIndU
Novartis has announced positive topline results from its pivotal Phase III RemIND trial evaluating oral remibrutinib in patients with chronic…
Johnson & Johnson Reports Promising OrigAMI-4 Trial Results
Johnson & Johnson has unveiled new data from its Phase 1b/2 OrigAMI-4 study, demonstrating that first-line treatment with investigational…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
MSD, Google Cloud Forge $1B AI Partnership
MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with…
Boehringer Expands AI Footprint With London Innovation Hub
Boehringer Ingelheim has announced a major expansion of its global Computational Innovation network with the launch…
Drug Research
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
Manufacturing
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
CordenPharma Leases New Lab Facility at Boulder’s Flatiron Park
BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility…
Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing
Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in…
AbbVie Invests $380M in North Chicago Manufacturing
AbbVie has unveiled plans to invest $380 million to construct two new active pharmaceutical ingredient (API)…
Johnson & Johnson Invests $1 Billion in Pennsylvania
Johnson & Johnson has announced plans to invest more than $1 billion in a next-generation cell therapy…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
